Healthcare & Assistive
From da Vinci surgical systems to rehab exoskeletons and elder-care companions, robotics is reshaping healthcare. This section grades what works in the clinic vs the marketing.
Topics in Healthcare & Assistive
24 articles
An analysis of shipping commercial exoskeletons for rehabilitation, separating hardware deployments from concept pitches, with focus on ReWalk, Ekso Bionics, and Cyberdyne HAL.
An evidence-based assessment of ElliQ, Paro, and Lovot in the elder-care sector. This report prioritizes shipped units and pilot deployments over announcements, analyzing India availability, landed costs, and the distinction between therapeutic companionship and physical assistance.
An evidence-based review of hospital Automated Mobile Robots, evaluating Aethon TUG and Fetch Robotics' Moxi against deployment data, safety standards, and Indian market entry barriers.
An analysis of shipping surgical robotics systems, focusing on soft-tissue manipulation technologies like da Vinci, Hugo, and Versius, with specific attention to Indian availability, pricing, and clinical deployment realities.
An analysis of the current state of robotic surgical systems, focusing on soft-tissue procedures, with specific attention to shipping hardware, pilot deployments, and the Indian healthcare context.
A grounded assessment of ReWalk, Ekso, and Cyberdyne HAL, focusing on FDA-cleared shipping hardware, clinical outcomes for neurological conditions, and the financial reality for Indian healthcare providers.
An evidence-based assessment of shipping elder-care hardware including ElliQ, Paro, and Lovot. Analysis covers technical capabilities, deployment pilots, and the stark realities of import costs and service infrastructure in India.
An analysis of Aethon TUG and Diligent Robotics Moxi deployments, focusing on real shipping hardware, India availability, and cost structures for hospital logistics.
An evidence-based assessment of ReWalk, Ekso, and Cyberdyne HAL exoskeletons. This article evaluates shipping hardware, clinical trial data, and India-specific availability, filtering out marketing claims from verifiable medical deployment metrics.
An evidence-based analysis of ElliQ, Paro, and Lovot. This report grades claims by shipping hardware availability, evaluates pilot deployments in nursing facilities, and assesses the feasibility of importing these systems to India amidst regulatory and pricing hurdles.
An evidence-based analysis of Automated Mobile Robots in healthcare settings. This article reviews shipping hardware from Aethon and Fetch Robotics, evaluating real-world deployment in logistics versus nursing assistance, with specific context on India's hospital infrastructure and pricing models.
An evidence-based analysis of the surgical robotics landscape, grading claims by shipping hardware. This article examines the da Vinci Xi/5, Medtronic Hugo, and CMR Versius systems, focusing on soft-tissue applications, Indian market availability, landed costs, and the regulatory reality behind the hype.
A grounded analysis of the da Vinci, Hugo, and Versius systems in the soft-tissue domain, focusing on shipping hardware, deployment metrics, and Indian market entry barriers.
An evidence-based review of the current state of medical rehabilitation exoskeletons. This article evaluates shipping hardware from ReWalk, Ekso Bionics, and Cyberdyne HAL against clinical evidence, regulatory status, and Indian market viability.
An analysis of shipping elder-care robots like Paro, ElliQ, and Lovot, focusing on hardware viability, pricing, and India availability. We grade claims by shipping hardware first, pilot deployments second, and announcements last.
An evidence-based assessment of Aethon TUG and Fetch Robotics Moxi in hospital logistics. This article evaluates shipping hardware, pilot deployments, and realistic ROI for Indian healthcare facilities, distinguishing between supply chain automation and nursing support robots.
An analysis of shipping surgical robotic systems in the soft-tissue sector, focusing on Intuitive Surgical, Medtronic, and CMR Surgical, with specific attention to Indian deployment costs and regulatory hurdles.
An evidence-based analysis of ReWalk, Ekso, and Cyberdyne exoskeletons, evaluating shipping hardware status, clinical efficacy data, and availability within the Indian healthcare market.
An evidence-based analysis of ElliQ, Paro, and Lovot deployment status, focusing on shipping hardware, pilot programs, and the specific regulatory and pricing challenges for the Indian elder-care market.
A grounded analysis of Aethon TUG and Diligent Robotics Moxi deployments. This report grades claims by shipping hardware, evaluates operational reliability in clinical settings, and assesses India availability and landed cost estimates for healthcare AMRs.
An analysis of the surgical robotics market focusing on hardware shipments, regulatory clearance, and actual deployment in India. This report grades claims by shipping status, evaluating da Vinci, Hugo, and Versius systems against real-world performance and landed costs.
An evidence-based assessment of commercial lower-limb exoskeletons, focusing on ReWalk, Ekso, and Cyberdyne HAL, with specific analysis on clinical efficacy and import viability for Indian healthcare providers.
An evidence-based review of shipping elder-care robots including ElliQ, Paro, and Lovot. We analyze their deployment status, hardware capabilities, and feasibility for the Indian market, separating marketing claims from shipping hardware.
An evidence-based review of hospital Autonomous Mobile Robots (AMRs), focusing on shipping hardware from Aethon Robotics and Diligent Robotics. We analyze pilot deployments versus mass adoption, with specific attention to India's market readiness and landed pricing models.